PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. raquel.gonzalez@isglobal.org.\', \'Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. raquel.gonzalez@isglobal.org.\', \'Manhiça Health Research Center (CISM), Manhiça, Mozambique. raquel.gonzalez@isglobal.org.\', \'ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.\', \'Manhiça Health Research Center (CISM), Manhiça, Mozambique.\', \'Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.\', \'BCNATAL | Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Clínic de Barcelona, Barcelona, Spain.\', \'Obstetrics and Gynecology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.\', \'Obstetrics and Gynecology Department, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.\', \'School of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.\', \'HM Puerta del Sur, Móstoles, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-020-04557-y
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32616063
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all